In a startlingly frank admission of the failure of their capitalist business model, a collection of some of the world's largest pharmaceutical companies said they need incentives to develop antibiotics to fight 'superbugs'. Apparently the giveaways that are being promoted in the TPP like longer patent lifetimes and the ability to sue governments that do anything to interfere with their profits is no longer enough for multinational corporations. They need direct cash infusion now.
One line in this story is particularly interesting. Not only does it indicate where the drug companies focus